Optical Coherence Tomography in Multiple Sclerosis
Autor: | Axel Petzold |
---|---|
EAN: | 9783319209708 |
eBook Format: | |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 28.08.2015 |
Untertitel: | Clinical Applications |
Kategorie: | |
Schlagworte: | CRION ION MS MSON Neuromyelitis Optica OCT RION chronic inflammatory optic neuropathy isolated optic neuritis multiple sclerosis optical coherence tomography optic neuritis relapsing isolated optic neuritis |
96,29 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
This book gives a clinical context to optical coherence tomography (OCT) findings, while considering the differential diagnosis and providing patient management guidance.
Relevant anatomical and technical aspects are discussed, followed by a pragmatic illustration of the use of OCT for the clinical spectrum of multiple sclerosis and optic neuritis, and finishing with information on monitoring ocular side effects of recently approved disease-modifying treatments in multiple sclerosis.
Optical Coherence Tomography in Multiple Sclerosis: Clinical Applications is aimed at clinical neurologists working with patients suffering from MS and general neurologists who see patients with visual symptoms in their daily practice. Ophthalmologists sharing clinical responsibilities with neurologists for patients under disease-modifying treatments will also find the book of interest.
Dr. Axel Petzold MD PhD is a Consultant Neuro-ophthalmologist at Moorfields Eye Hospital, Head of the Dutch Neuro-ophthalmology expertise centre at the VU Medical Centre, Amsterdam, The Netherlands and Honorary Senior Lecturer at the UCL Institute of Neurology, Queen Square, London, United Kingdom. Dr Petzold has contributed to developing and validating biomarkers for inflammation and neurodegeneration in multiple sclerosis and optic neuropathies. He is currently involved in setting up and integrating new imaging techniques for retinal signs of inflammation and neurodegeneration. Dr Petzold has published >190 articles in peer reviewed Journals (77 first author) with a cumulative impact factor >720 and a H-Index of 41.